BACKGROUND: Monitoring and evaluation of antiretroviral treatment (ART) scale-up has been challenging in resource-limited settings. We describe an innovative cell-phone-based and internet-based reporting system (TRACnet) utilized in Rwanda. METHODS: From January 2004 to June 30, 2010, all health facilities with ART services submitted standardized monthly aggregate reports of key indicators. National cohort data were analyzed to examine trends in characteristics of patients initiating ART and cumulative cohort outcomes. Estimates of HIV-infected patients eligible for ART were obtained from Joint United Nations Program on HIV/AIDS (Estimation and Projection Package-Spectrum, 2010). RESULTS: By June 30, 2010, 295 (65%) of 451 health centers, District and referral hospitals provided ART services; of these, 255 (86%) were located outside Kigali, the capital. Cell phone-based and internet-based reporting was used by 253 (86%) and 42 (14%), respectively. As of June 30, 2010, 83,041 patients were alive on ART, 6171 (6%) had died, and 9621 (10%) were lost-to-follow-up. Of those alive on ART, 7111 (8.6%) were children, 50,971 (61.4%) were female, and 1823 (2.2%) were on a second-line regimen. The proportion of all patients initiating ART at World Health Organization clinical stages 3 and 4 declined from 65% in 2005 to 27% in 2010. National ART coverage of eligible patients increased from 13% in 2005 to 79% in 2010. CONCLUSIONS: Rwanda has successfully expanded ART access and achieved high national ART coverage among eligible patients. TRACnet captured essential data about the ART program during rapid scale-up. Cell phone-based and internet-based reporting may be useful for monitoring and evaluation of similar public health initiatives in other resource-limited settings.
BACKGROUND: Monitoring and evaluation of antiretroviral treatment (ART) scale-up has been challenging in resource-limited settings. We describe an innovative cell-phone-based and internet-based reporting system (TRACnet) utilized in Rwanda. METHODS: From January 2004 to June 30, 2010, all health facilities with ART services submitted standardized monthly aggregate reports of key indicators. National cohort data were analyzed to examine trends in characteristics of patients initiating ART and cumulative cohort outcomes. Estimates of HIV-infectedpatients eligible for ART were obtained from Joint United Nations Program on HIV/AIDS (Estimation and Projection Package-Spectrum, 2010). RESULTS: By June 30, 2010, 295 (65%) of 451 health centers, District and referral hospitals provided ART services; of these, 255 (86%) were located outside Kigali, the capital. Cell phone-based and internet-based reporting was used by 253 (86%) and 42 (14%), respectively. As of June 30, 2010, 83,041 patients were alive on ART, 6171 (6%) had died, and 9621 (10%) were lost-to-follow-up. Of those alive on ART, 7111 (8.6%) were children, 50,971 (61.4%) were female, and 1823 (2.2%) were on a second-line regimen. The proportion of all patients initiating ART at World Health Organization clinical stages 3 and 4 declined from 65% in 2005 to 27% in 2010. National ART coverage of eligible patients increased from 13% in 2005 to 79% in 2010. CONCLUSIONS: Rwanda has successfully expanded ART access and achieved high national ART coverage among eligible patients. TRACnet captured essential data about the ART program during rapid scale-up. Cell phone-based and internet-based reporting may be useful for monitoring and evaluation of similar public health initiatives in other resource-limited settings.
Authors: Eugene Mutimura; Diane Addison; Kathryn Anastos; Donald Hoover; Jean Claude Dusingize; Ben Karenzie; Isabelle Izimukwiye; Leo Mutesa; Sabin Nsanzimana; Denis Nash Journal: AIDS Date: 2015-01-02 Impact factor: 4.177
Authors: Agnes Binagwaho; Paul E Farmer; Sabin Nsanzimana; Corine Karema; Michel Gasana; Jean de Dieu Ngirabega; Fidele Ngabo; Claire M Wagner; Cameron T Nutt; Thierry Nyatanyi; Maurice Gatera; Yvonne Kayiteshonga; Cathy Mugeni; Placidie Mugwaneza; Joseph Shema; Parfait Uwaliraye; Erick Gaju; Marie Aimee Muhimpundu; Theophile Dushime; Florent Senyana; Jean Baptiste Mazarati; Celsa Muzayire Gaju; Lisine Tuyisenge; Vincent Mutabazi; Patrick Kyamanywa; Vincent Rusanganwa; Jean Pierre Nyemazi; Agathe Umutoni; Ida Kankindi; Christian Ntizimira; Hinda Ruton; Nathan Mugume; Denis Nkunda; Espérance Ndenga; Joel M Mubiligi; Jean Baptiste Kakoma; Etienne Karita; Claude Sekabaraga; Emmanuel Rusingiza; Michael L Rich; Joia S Mukherjee; Joseph Rhatigan; Corrado Cancedda; Didi Bertrand-Farmer; Gene Bukhman; Sara N Stulac; Neo M Tapela; Cassia van der Hoof Holstein; Lawrence N Shulman; Antoinette Habinshuti; Matthew H Bonds; Michael S Wilkes; Chunling Lu; Mary C Smith-Fawzi; JaBaris D Swain; Michael P Murphy; Alan Ricks; Vanessa B Kerry; Barbara P Bush; Richard W Siegler; Cori S Stern; Anne Sliney; Tej Nuthulaganti; Injonge Karangwa; Elisabetta Pegurri; Ophelia Dahl; Peter C Drobac Journal: Lancet Date: 2014-04-04 Impact factor: 79.321
Authors: Felix R Kayigamba; Mirjam I Bakker; Hadassa Fikse; Veronicah Mugisha; Anita Asiimwe; Maarten F Schim van der Loeff Journal: PLoS One Date: 2012-05-11 Impact factor: 3.240
Authors: Agnes Binagwaho; Cameron T Nutt; Vincent Mutabazi; Corine Karema; Sabin Nsanzimana; Michel Gasana; Peter C Drobac; Michael L Rich; Parfait Uwaliraye; Jean Pierre Nyemazi; Michael R Murphy; Claire M Wagner; Andrew Makaka; Hinda Ruton; Gita N Mody; Danielle R Zurovcik; Jonathan A Niconchuk; Cathy Mugeni; Fidele Ngabo; Jean de Dieu Ngirabega; Anita Asiimwe; Paul E Farmer Journal: Global Health Date: 2013-08-30 Impact factor: 4.185
Authors: Paul E Farmer; Cameron T Nutt; Claire M Wagner; Claude Sekabaraga; Tej Nuthulaganti; Jonathan L Weigel; Didi Bertrand Farmer; Antoinette Habinshuti; Soline Dusabeyesu Mugeni; Jean-Claude Karasi; Peter C Drobac Journal: BMJ Date: 2013-01-18
Authors: Felix R Kayigamba; Mirjam I Bakker; Veronicah Mugisha; Ludwig De Naeyer; Michel Gasana; Frank Cobelens; Maarten Schim van der Loeff Journal: PLoS One Date: 2013-09-16 Impact factor: 3.240